| Literature DB >> 31775113 |
Jéssica da Silva Ferreira1, Fernanda Marques de Carvalho2, Maria Cristina Vidal Pessolani2, João Marcelo Azevedo de Paula Antunes3, Ilanna Vanessa Pristo de Medeiros Oliveira3, Gabriela Hémylin Ferreira Moura3, Richard Wayne Truman4, Maria Teresa Peña4, Rahul Sharma4, Malcolm S Duthie5, Ricardo José de Paula Souza E Guimarães6, Amanda Nogueira Brum Fontes7, Philip NoelSuffys7, Douglas McIntosh8.
Abstract
Leprosy was recognized as a zoonotic disease, associated with nine-banded armadillos (Dasypus novemcinctus) in the Southern United States of America in 2011. In addition, there is growing evidence to support a role for armadillos in zoonotic leprosy in South America. The current study evaluated twenty specimens of the six-banded armadillo (Euphractus sexcinctus), collected from rural locations in the state of Rio Grande do Norte (RN), Brazil for evidence of infection with Mycobacterium leprae. Serum was examined using two "in-house" enzyme-linked immunosorbent assays (ELISAs) and via two commercially available (ML flow and NDO-LID®) immunochromatographic lateral flow (LF) tests, for detection of the PGL-I and/or LID-1 antigens of the bacterium. The presence of M. leprae DNA in liver tissue was examined using the multi-copy, M. leprae-specific repetitive element (RLEP), as target in conventional and nested PCR assays. Molecular and anti-PGL-I-ELISA data indicated that 20/20 (100 %) of the armadillos were infected with M. leprae. The corresponding detection levels recorded with the LF tests were 17/20 (85 %) and 16/20 (85 %), for the NDO-LID® and ML flow tests, respectively. Our results indicate that, in common with D. novemcinctus, six banded armadillos (a species hunted and reared as a food-source in some regions of Brazil, including RN), represent a potential reservoir of M. leprae and as such, their role in a possible zoonotic cycle of leprosy within Brazil warrants further investigation.Entities:
Keywords: Armadillo; Immunodiagnostics; Leprosy; PCR; Zoonotic
Mesh:
Year: 2019 PMID: 31775113 DOI: 10.1016/j.cimid.2019.101397
Source DB: PubMed Journal: Comp Immunol Microbiol Infect Dis ISSN: 0147-9571 Impact factor: 2.268